2025 ICD-10 PCS INDEX TERMS STARTING WITH 3

  • Introduction Products of Conception to No Qualifier with Anti-inflammatory, Percutaneous Approach - 3E0E33Z
  • Introduction Products of Conception to No Qualifier with Nutritional Substance, Percutaneous Approach - 3E0E36Z
  • Introduction Products of Conception to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach - 3E0E37Z
  • Introduction Products of Conception to No Qualifier with Anesthetic Agent, Percutaneous Approach - 3E0E3BZ
  • Introduction Products of Conception to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E0E3GC
  • Introduction Products of Conception to No Qualifier with Radioactive Substance, Percutaneous Approach - 3E0E3HZ
  • Introduction Products of Conception to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E0E3KZ
  • Introduction Products of Conception to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach - 3E0E3NZ
  • Introduction Products of Conception to Other Gas with Gas, Percutaneous Approach - 3E0E3SF
  • Introduction Products of Conception to No Qualifier with Destructive Agent, Percutaneous Approach - 3E0E3TZ
  • Introduction Products of Conception to Other Substance with Other Therapeutic Substance, Percutaneous Endoscopic Approach - 3E0E4GC
  • Introduction Products of Conception to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0E704
  • Introduction Products of Conception to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0E705
  • Introduction Products of Conception to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0E70M
  • Introduction Products of Conception to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Approach - 3E0E728
  • Introduction Products of Conception to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Approach - 3E0E729
  • Introduction Products of Conception to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Approach - 3E0E73Z
  • Introduction Products of Conception to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Approach - 3E0E76Z
  • Introduction Products of Conception to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Approach - 3E0E77Z
  • Introduction Products of Conception to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Approach - 3E0E7BZ
  • Introduction Products of Conception to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Approach - 3E0E7GC
  • Introduction Products of Conception to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Approach - 3E0E7HZ
  • Introduction Products of Conception to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Approach - 3E0E7KZ
  • Introduction Products of Conception to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Approach - 3E0E7NZ
  • Introduction Products of Conception to Other Gas with Gas, Via Natural or Artificial Opening Approach - 3E0E7SF
  • Introduction Products of Conception to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Approach - 3E0E7TZ
  • Introduction Products of Conception to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0E804
  • Introduction Products of Conception to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0E805
  • Introduction Products of Conception to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0E80M
  • Introduction Products of Conception to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach - 3E0E828
  • Introduction Products of Conception to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach - 3E0E829
  • Introduction Products of Conception to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Endoscopic Approach - 3E0E83Z
  • Introduction Products of Conception to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0E86Z
  • Introduction Products of Conception to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0E87Z
  • Introduction Products of Conception to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Endoscopic Approach - 3E0E8BZ
  • Introduction Products of Conception to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0E8GC
  • Introduction Products of Conception to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0E8HZ
  • Introduction Products of Conception to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0E8KZ
  • Introduction Products of Conception to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Endoscopic Approach - 3E0E8NZ
  • Introduction Products of Conception to Other Gas with Gas, Via Natural or Artificial Opening Endoscopic Approach - 3E0E8SF
  • Introduction Products of Conception to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Endoscopic Approach - 3E0E8TZ
  • Introduction Respiratory Tract to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach - 3E0F304
  • Introduction Respiratory Tract to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E0F305
  • Introduction Respiratory Tract to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0F30M
  • Introduction Respiratory Tract to Oxazolidinones with Anti-infective, Percutaneous Approach - 3E0F328
  • Introduction Respiratory Tract to Other Anti-infective with Anti-infective, Percutaneous Approach - 3E0F329
  • Introduction Respiratory Tract to No Qualifier with Anti-inflammatory, Percutaneous Approach - 3E0F33Z
  • Introduction Respiratory Tract to No Qualifier with Nutritional Substance, Percutaneous Approach - 3E0F36Z
  • Introduction Respiratory Tract to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach - 3E0F37Z
  • Introduction Respiratory Tract to No Qualifier with Anesthetic Agent, Percutaneous Approach - 3E0F3BZ
  • Introduction Respiratory Tract to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E0F3GC
  • Introduction Respiratory Tract to No Qualifier with Radioactive Substance, Percutaneous Approach - 3E0F3HZ
  • Introduction Respiratory Tract to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E0F3KZ
  • Introduction Respiratory Tract to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach - 3E0F3NZ
  • Introduction Respiratory Tract to Nitric Oxide with Gas, Percutaneous Approach - 3E0F3SD
  • Introduction Respiratory Tract to Other Gas with Gas, Percutaneous Approach - 3E0F3SF
  • Introduction Respiratory Tract to No Qualifier with Destructive Agent, Percutaneous Approach - 3E0F3TZ
  • Introduction Respiratory Tract to Other Substance with Other Therapeutic Substance, Percutaneous Endoscopic Approach - 3E0F4GC
  • Introduction Respiratory Tract to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0F704
  • Introduction Respiratory Tract to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0F705
  • Introduction Respiratory Tract to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0F70M
  • Introduction Respiratory Tract to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Approach - 3E0F728
  • Introduction Respiratory Tract to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Approach - 3E0F729
  • Introduction Respiratory Tract to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Approach - 3E0F73Z
  • Introduction Respiratory Tract to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Approach - 3E0F76Z
  • Introduction Respiratory Tract to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Approach - 3E0F77Z
  • Introduction Respiratory Tract to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Approach - 3E0F7BZ
  • Introduction Respiratory Tract to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Approach - 3E0F7GC
  • Introduction Respiratory Tract to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Approach - 3E0F7HZ
  • Introduction Respiratory Tract to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Approach - 3E0F7KZ
  • Introduction Respiratory Tract to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Approach - 3E0F7NZ
  • Introduction Respiratory Tract to Nitric Oxide with Gas, Via Natural or Artificial Opening Approach - 3E0F7SD
  • Introduction Respiratory Tract to Other Gas with Gas, Via Natural or Artificial Opening Approach - 3E0F7SF
  • Introduction Respiratory Tract to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Approach - 3E0F7TZ
  • Introduction Respiratory Tract to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0F804
  • Introduction Respiratory Tract to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0F805
  • Introduction Respiratory Tract to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0F80M
  • Introduction Respiratory Tract to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach - 3E0F828
  • Introduction Respiratory Tract to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach - 3E0F829
  • Introduction Respiratory Tract to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Endoscopic Approach - 3E0F83Z
  • Introduction Respiratory Tract to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0F86Z
  • Introduction Respiratory Tract to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0F87Z
  • Introduction Respiratory Tract to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Endoscopic Approach - 3E0F8BZ
  • Introduction Respiratory Tract to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0F8GC
  • Introduction Respiratory Tract to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0F8HZ
  • Introduction Respiratory Tract to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0F8KZ
  • Introduction Respiratory Tract to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Endoscopic Approach - 3E0F8NZ
  • Introduction Respiratory Tract to Nitric Oxide with Gas, Via Natural or Artificial Opening Endoscopic Approach - 3E0F8SD
  • Introduction Respiratory Tract to Other Gas with Gas, Via Natural or Artificial Opening Endoscopic Approach - 3E0F8SF
  • Introduction Respiratory Tract to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Endoscopic Approach - 3E0F8TZ
  • Introduction Upper GI to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach - 3E0G304
  • Introduction Upper GI to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E0G305
  • Introduction Upper GI to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0G30M
  • Introduction Upper GI to Oxazolidinones with Anti-infective, Percutaneous Approach - 3E0G328
  • Introduction Upper GI to Other Anti-infective with Anti-infective, Percutaneous Approach - 3E0G329
  • Introduction Upper GI to No Qualifier with Anti-inflammatory, Percutaneous Approach - 3E0G33Z
  • Introduction Upper GI to No Qualifier with Nutritional Substance, Percutaneous Approach - 3E0G36Z
  • Introduction Upper GI to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach - 3E0G37Z
  • Introduction Upper GI to No Qualifier with Anesthetic Agent, Percutaneous Approach - 3E0G3BZ
  • Introduction Upper GI to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E0G3GC